🔗 Share this article

A shadow market for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with numerous of participants share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the drug there before directing customers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Voice Concerns

Nevertheless, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users injecting products of unknown origin.

Several experts stated the popularity for retatrutide could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking fines, legal action or prison.

Service Response and Content Elimination

According to the social media company, the service has taken down problematic material and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the service safe and investing in enhancing enforcement strategies.

Online Trading Operations

Research also found communities with up to nine thousand members marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, positive testimonials and detailed instructions for preparing or injecting at home.

After moments of joining one group, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about weight, health issues or past usage.

Item Information and Pricing

Inside these groups, posts show dark colored parcels with postal service labels, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When questioned how long a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for the messaging service stated it regularly moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the research behind retatrutide is sound, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, individuals are using social media. But counterfeit injections are highly risky. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she explained.

Her team has previously encountered individuals injured by personal administration from unverified sources. “We understand the disappointment, but buying from Telegram or communication platforms is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose users to possibly significant medical dangers”.